MEMORANDUM AND ORDER ON DEFENDANTS’ MOTION TO DISMISS AMENDED COMPLAINT
In this qui tam action, relator Heidi Heineman-Guta, a former employee of defendants Guidant Corp. and Boston Scientific Corp. (BSC)
PROCEDURAL HISTORY
In her original Complaint, filed under seal in November of 2009, Heineman-Guta accused defendants of illegally promoting the off-label use of cardiac rhythm management devices and the payment of kickbacks to physicians to induce them to select and recommend the devices for patient implants. The United States, after a preliminary investigation, declined to intervene in October of 2011, and the court ordered the Complaint unsealed. Subsequently, in January of 2012, Heineman-Guta filed the FAC, focusing only on the kickback allegations. The court heard arguments on defendants’ motion to dismiss the FAC on July 2, 2012.
ALLEGATIONS
Heineman-Guta worked as an account manager for the heart failure management group at Guidant, later BSC, from April of 2003 until November of 2007. During her tenure, she observed and participated in Guidanf/BSC’s scheme to induce and reward doctors for referring and implanting Guidant/BSC cardiac rhythm management devices. This scheme included: (1) offering referring and implanting physicians valuable trips, entertainment, and/or grants; (2) treating referring and implanting physicians to lavish meals; (3) making payments, in the guise of honoraria and speaking fees, to referring and implanting physicians for participating in case studies; (4) remunerating loyal referring and implanting physicians for “participation” in sham clinical trials; and/or (5) providing similar benefits and job placement assistance to medical residents and fellows to
DISCUSSION
“To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal,
Heineman-Guta’s claims are based on 31 U.S.C. § 3729(a)(1) and (a)(2).
Defendants argue that Heine-man-Guta’s claims must be dismissed for lack of subject matter jurisdiction based on the first-to-file bar.
Defendants rely on two earlier-filed complaints as barring Heineman-Guta’s claims: United States ex rel. George v. Boston Scientific Corp., No. H-07-02467 (S.D.Tex.2007) (George Complaint), filed on November 6, 2006
The George Complaint alleged that defendants “promoted the FlexView microwave surgical-ablation system for an off-label use and that these promotional activities caused physicians and hospitals to submit false claims for reimbursement from Medicare or Medicaid.” United States ex rel. Bennett
The Bennett Complaint, on the other hand, alleged, that
[sjince at least 2003, and continuing through [at least 2008], Boston Scientific Corporation (and, prior to being acquired by Boston Scientific, Guidant Corporation) has engaged in an illegal kickback scheme within its Cardiac Rhythm Management (“CRM”) division designed to induce physicians and hospitals to use Boston Scientific pacemakers, internal cardiac defibrillators (“ICD’s”), cardiac resynchronization therapy (“CRT’s”), and cardiac resynchronization therapy with defibrillators (“CRTD’s”), thereby increasing the Company’s market share of these devices.
Bennett Compl. ¶ 3. This alleged scheme included
inter alia, (1) providing] doctors and hospitals with kickbacks in the form of follow-up medical services in exchange for the providers’ use of BSC’s cardiac rhythm devices; (2) inducting] doctors and hospitals to bill for medical services and procedures they do not perform; (3) requiring] BSC sales personnel to provide medical care in the absence of a licensed physician or staff member; and (4) improperly conducting Medicare billing for physicians and hospitals through non-licensed, non-medical staff; (5) providing] monetary “grants” to foundations set up by physicians and physician groups in return for favored status by such physicians; and (6) sponsoring] dinner meetings for implanting physi*39 dans to invite potential “referring physicians” to, in order for the implanting physician to increase the number of patients he receives for implants from those referring physicians. In most cases, the benefitting implanting physician also receives an “honorarium” for speaking about his or her expertise at the program.
Id. ¶ 4.
Heineman-Guta does not deny that the Bennett Complaint disclosed a scheme nearly identical to the one alleged in the FAC, but asserts that it does not qualify as a first-filed bar under an exception to the first-to-file rule established by the Sixth Circuit.
One important caveat to this first-to-file rule ... is that, in order to preclude later-filed qui tam actions, the allegedly first-filed qui tam complaint must not itself be jurisdictionally or otherwise barred. See Walburn v. Lockheed Martin Corp.], 431 F.3d [966,] 972 [ (6th Cir.2005) ] (finding that an earlier filed complaint’s failure to comply with Rule 9(b) rendered it legally infirm from its inception, and thus unable to preempt a later-filed action); Campbell v. Redding Med. Ctr.,421 F.3d 817 , 825 (9th Cir. 2005) (holding that “the first-to-file rule of § 3730(b)(5) bars only subsequent complaints filed after a complaint that fulfills the jurisdictional prerequisites of § 3730(e)(4)”). Indeed, if the first complaint is either jurisdictionally precluded, see 31 U.S.C. § 3730(e), or legally incapable of serving as a complaint, see Fed.R.Civ.P. 9(b); United States ex rel. Bledsoe v. Cmty. Health Sys., Inc.,501 F.3d 493 , 504 (6th Cir.2007) ... then it does not properly qualify as a “pending action” brought under the FCA, 31 U.S.C. § 3730(b)(5). However, if the first-filed qui tam action has been dismissed on its merits or on some other grounds not related to its viability as a federal action, it can still preclude a later-filed, but possibly more meritorious, qui tam complaint under the first-to-file rule. See Lujan,243 F.3d at 1188 .
United States ex rel. Poteet v. Medtronic, Inc.,
This court has previously “share[d] the skepticism expressed by Judge McKeague in his concurring opinion in Poteet, whether the [dismissal on the merits element] of the first-to-file requirements found by the Sixth Circuit ... is an accurate (or wise) interpretation of the qui tam statute.” United States ex rel. Poteet v. Lenke,
We are unconvinced. Nothing in the language of Section 3730(b)(5) incorporates the particularity requirement of Rule 9(b), which militates against reading such a requirement into the statute. The statutory text imposes a bar on complaints related to earlier-filed, “pending” actions. The command is simple: as long as a first-filed complaint remains pending, no related complaint may be filed. Further, Rule 9(b) is designed to protect defendants in fraud cases from frivolous accusations and allow them to prepare an appropriate response. Section 3730(b) is designed to allow recovery when a qui tam relator puts the government on notice of potential fraud being worked against the government, but to bar copycat actions that provide no additional material information. As the district court found, a complaint may provide the government sufficient information to launch an investigation of a fraudulent scheme even if the complaint does not meet the particularity standards of Rule 9(b). [United States ex rel.] Batiste [v. SLM Corp.], 740 F.Supp.2d [98,] 104 [ (D.D.C. 2010) (Batiste I) ]. Imposing the heightened pleading standard, moreover, would create a strange judicial dynamic, potentially requiring one district court to determine the sufficiency of a complaint filed in another district court, and possibly creating a situation in which the two district courts disagree on a complaint’s sufficiency.
United States ex rel. Batiste v. SLM Corp.,
This court agrees with the reasoning of the D.C. Court of Appeals and the D.C. District Court.
[I]t is entirely plausible that a complaint may provide sufficient information to cause the government to launch its own investigation of a fraudulent scheme without providing enough information under Rule 9(b) to protect the defendant’s interests. In other words, there might be a situation where there is sufficient notice for the government, but not for the defendant. In that event, it would be proper to dismiss the complaint against the defendant for purposes of Rule 9(b) but to allow the preemption of any subsequent related actions for purposes of the “first-to-file” rule. After all, once the whistle has sounded, the government has little need for additional whistle-blowers.
Batiste I,
Furthermore, this case well demonstrates the “strange judicial dynamic” that
For present purposes it is sufficient that this court hold that the Bennett Complaint is pled in sufficient detail to act as a first-filed complaint barring the FAC. Like the FAC, the Bennett Complaint disclosed a kickback scheme to promote defendants’ cardiac rhythm management products. The Bennett Complaint described, inter alia, the same types of kickbacks—grants, honoraria, and lavish meals—as disclosed in the FAC. Although the FAC provides different and somewhat richer details, the Bennett Complaint exposed all of the essential facts of the scheme, and thus acts as a bar precluding the filing of the FAC.
CONCLUSION
For the foregoing reasons, defendants’ motion to dismiss is ALLOWED. The Clerk is directed to enter an order of dismissal for lack of subject matter jurisdiction and close the case.
SO ORDERED.
Notes
. Guidant was acquired by BSC in 2006.
. These and other provisions of the FCA were significantly amended by the Fraud Enforcement and Recovery Act of 2009 (FERA), Pub.L. No. 111-21, 123 Stat. 1617 (2009). Most FERA amendments took effect on May 20, 2009. The amendment to Section 3729(a)(2) applies retroactively to claims pending on or after June 7, 2008. See United States ex rel. Carpenter v. Abbott Labs., Inc.,
. The United States filed a “statement of interest” regarding defendants' motion to dismiss, but took no position on the contention that the suit is barred because of the first-to-file rule.
. The George Complaint was initially filed in the Northern District of Illinois in 2006, and was transferred to the Southern District of Texas in 2007.
. The relator in George and Bennett is the same person, whose name changed from George to Bennett after the filing of the first complaint.
. Although the George Complaint also alleged kickbacks, they are "in the form of free advertising, press, and referral services” relating to the off-label promotion of a different line of products. George Compl. V 10.
. Heineman-Guta also relies on Campbell v. Redding Med. Ctr.,
. Rule 9(b) requires that “[i]n alleging fraud ... a party must state with particularity the circumstances constituting fraud....” Heine-man-Guta argues that, unlike her FAC, the Bennett Complaint failed the Rule 9(b) test because it did not provide any examples of specific incidents of kickbacks.
. The First Circuit has yet to rule on the issue.
. The holding of the D.C. Circuit and the D.C. District Court is faithful to the purpose of the qui tam statute. It is highly unlikely that prosecutors—the audience to which the qui tam notice is directed—would decline to investigate serious allegations of fraud against the government merely because a complaint failed to meet the particularity requirement of Rule 9(b), or for that matter, that they would even think it desirable to conduct a Rule 9(b) screening of a qui tam complaint before undertaking an investigation of its allegations. Moreover, in the FCA context, where the complaint is typically sealed, prosecutors must decide whether to initiate an investigation before having the benefit (such as it might be) of a judicial determination of the complaint's sufficiency under Rule 9(b).
. The court can imagine, as suggested by counsel for Heineman-Guta at oral argument,
. Defendants contend that dismissal is also warranted on several alternative grounds. However, because the Bennett Complaint serves as an absolute bar, it is unnecessary to address defendants' other arguments.
